| 摘要 |
The present invention provides a drug delivery composition comprising: a protein drug or an anti-inflammatory drug in a carrier or a support essentially comprising a polysaccharide such as a polysaccharide and the like used in a pharmaceutical dosage form such as in an injectable form and the like or in a preparation for tissue engineering; and a cross-linked product of hyaluronic acid, a polysaccharide, and a biocompatible polymer for controlling the release amount. According to the present invention, the drug delivery composition can show an extended release property, improves tissue engineering healing, is safe, and can reduce manufacturing costs. |
